BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6461061)

  • 1. Degradation of amyloid proteins by different serine proteases.
    Skogen B; Natvig JB
    Scand J Immunol; 1981 Oct; 14(4):389-96. PubMed ID: 6461061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do serine proteases degrade amyloid A fibrils?
    Teppo AM; Maury CP
    Scand J Immunol; 1983 Oct; 18(4):363-6. PubMed ID: 6196837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of the amyloid A fibril-degrading activity of human serum.
    Teppo AM; Maury CP; Wegelius O
    Scand J Immunol; 1982 Oct; 16(4):309-14. PubMed ID: 6183739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of serum amyloid A and apolipoproteins by serum proteases.
    Bausserman LL; Herbert PN
    Biochemistry; 1984 May; 23(10):2241-5. PubMed ID: 6428449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid 'degrading factor activity': a non-specific calcium-mediated effect.
    Scott DL; Bracken P; Bacon PA; Husby G
    Clin Sci (Lond); 1985 Mar; 68(3):333-9. PubMed ID: 3918827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of amyloid-related serum protein SAA by a component present in rabbit and human serum.
    Skogen B; Natvig JB; Bøorresen AL; Berg K
    Scand J Immunol; 1980; 11(6):643-8. PubMed ID: 6777866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro enhancement of AA-degrading activity in human plasma with the plasminogen activator streptokinase.
    Skogen B; Natvig JB
    Scand J Immunol; 1981 Dec; 14(6):637-41. PubMed ID: 6210954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elastase-type proteases on the surface of human blood monocytes: possible role in amyloid formation.
    Lavie G; Zucker-Franklin D; Franklin EC
    J Immunol; 1980 Jul; 125(1):175-80. PubMed ID: 6991601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin D activity protects against development of type AA amyloid fibrils.
    van der Hilst JC; Kluve-Beckerman B; van der Meer JW; Simon A
    Eur J Clin Invest; 2009 May; 39(5):412-6. PubMed ID: 19740371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin B generates the most common form of amyloid A (76 residues) as a degradation product from serum amyloid A.
    Yamada T; Liepnieks JJ; Kluve-Beckerman B; Benson MD
    Scand J Immunol; 1995 Jan; 41(1):94-7. PubMed ID: 7824894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes.
    Lavie G; Zucker-Franklin D; Franklin EC
    J Exp Med; 1978 Oct; 148(4):1020-31. PubMed ID: 702058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytic properties of serine proteases. 2. Comparison between human urinary kallikrein and human urokinase, bovine beta-trypsin, bovine thrombin, and bovine alpha-chymotrypsin.
    Ascenzi P; Menegatti E; Guarneri M; Bortolotti F; Antonini E
    Biochemistry; 1982 May; 21(10):2483-90. PubMed ID: 7046788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of human amyloid protein AA and its related serum protein, SAA.
    Skogen B; Sletten K; Lea T; Natvig JB
    Scand J Immunol; 1983 Jan; 17(1):83-8. PubMed ID: 6552032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo.
    Husebekk A; Skogen B; Husby G; Marhaug G
    Scand J Immunol; 1985 Mar; 21(3):283-7. PubMed ID: 3922050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of protein SAA to an AA-like fragment by enzymes of monocytic origin.
    Skogen B; Thorsteinsson L; Natvig JB
    Scand J Immunol; 1980; 11(5):533-40. PubMed ID: 6155692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of amyloid proteins with protease I from Aspergillus oryzae. In vivo increase in SAA clearance rate after enzyme infusion.
    Skogen B; Amundsen E
    Scand J Immunol; 1982 Dec; 16(6):509-14. PubMed ID: 6760382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of amyloid A and serum amyloid A by red blood cell haemolysate in patients with familial mediterranean fever.
    Shainkin-Kestenbaum R; Winikoff Y; Zimlichman S; Gorodischer R; Pras M
    Eur J Clin Invest; 1984 Oct; 14(5):398-401. PubMed ID: 6437839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active site mapping of the serine proteases human leukocyte elastase, cathepsin G, porcine pancreatic elastase, rat mast cell proteases I and II. Bovine chymotrypsin A alpha, and Staphylococcus aureus protease V-8 using tripeptide thiobenzyl ester substrates.
    Harper JW; Cook RR; Roberts CJ; McLaughlin BJ; Powers JC
    Biochemistry; 1984 Jun; 23(13):2995-3002. PubMed ID: 6380580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of plasma prekallikrein and inactive renin by puff adder venom.
    Morris BJ; Lawrence CH; Catanzaro DF
    Clin Exp Pharmacol Physiol; 1980; 7(5):563-7. PubMed ID: 6450010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temperature-induced dissociation of serum amyloid protein SAA.
    Linke RP
    Z Immunitatsforsch Immunobiol; 1979 Feb; 155(3):255-61. PubMed ID: 85376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.